TAMRO Capital Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-63,960
Closed -$1.37M 69
2015
Q3
$1.37M Sell
63,960
-955,888
-94% -$21.3M 0.16% 55
2015
Q2
$20.4M Sell
1,019,848
-1,357,164
-57% -$23.8M 1.74% 27
2015
Q1
$37M Sell
2,377,012
-550,592
-19% -$8.32M 2.56% 4
2014
Q4
$40.3M Sell
2,927,604
-731,580
-20% -$8.96M 2.71% 2
2014
Q3
$36.6M Sell
3,659,184
-2,055,512
-36% -$21M 2.43% 3
2014
Q2
$56.7M Sell
5,714,696
-1,583,588
-22% -$14M 2.87% 1
2014
Q1
$75.5M Sell
7,298,284
-292,980
-4% -$3.03M 3.29% 1
2013
Q4
$67.2M Sell
7,591,264
-209,432
-3% -$1.66M 2.77% 1
2013
Q3
$55M Sell
7,800,696
-548,740
-7% -$3.48M 2.28% 4
2013
Q2
$46.9M Buy
+8,349,436
New +$40M 2.09% 9

Other funds holding DXCM

TAMRO Capital Partners's DXCM Position: Q4 2015 in Review

TAMRO Capital Partners sold out of DexCom (DXCM) in Q4 2015, closing a stake of 63,960 shares — an estimated $1.37M sold.

TAMRO Capital Partners first reported a position in DXCM in Q2 2013 and held it in 10 quarters. The position peaked at $75.5M in Q1 2014. 286 funds tracked by Wall St. Rank hold DXCM as of Q4 2015.

  • TAMRO Capital Partners reported no remaining DexCom position as of Q4 2015 after selling out during the quarter.
  • TAMRO Capital Partners sold 63,960 DexCom shares in Q4 2015, an estimated $1.37M.
  • TAMRO Capital Partners first reported a position in DexCom in Q2 2013 and held it in 10 quarters.
  • TAMRO Capital Partners's DexCom position peaked at $75.5M in Q1 2014.
  • 286 funds tracked by Wall St. Rank held DexCom as of Q4 2015.

Based on TAMRO Capital Partners's 13F filing for Q4 2015, filed 21 Jan 2016.